---
title: "Mingchen Health: Plans to repurchase shares for 30 million to 50 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241410826.md"
description: "Mingchen Health announced that the company plans to repurchase shares for an amount between 30 million yuan and 50 million yuan, with a repurchase price not exceeding 23 yuan per share. The expected number of shares to be repurchased is between 1.3043 million and 2.1739 million shares, accounting for 0.4894% to 0.8156% of the total share capital. The repurchased shares will be used for equity incentives or employee stock ownership plans, and the repurchase period will not exceed 12 months after the board of directors' approval. Company executives and controlling shareholders have no plans to reduce their holdings in the next six months"
datetime: "2025-05-22T10:47:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241410826.md)
  - [en](https://longbridge.com/en/news/241410826.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241410826.md)
generator: "portal-rs"
---

# Mingchen Health: Plans to repurchase shares for 30 million to 50 million yuan

Mingchen Health announced that the company plans to repurchase shares with funds ranging from 30 million to 50 million yuan, with a repurchase price not exceeding 23 yuan per share. The estimated number of shares to be repurchased is approximately 1.3043 million to 2.1739 million shares, accounting for 0.4894% to 0.8156% of the company's total share capital. The repurchased shares will be used for the company's equity incentive plan or employee stock ownership plan. The repurchase period will not exceed 12 months from the date the board of directors approves the repurchase plan. The company's directors, supervisors, senior management, and controlling shareholders have no specific plans for reduction in the next six months and during the repurchase period

### Related Stocks

- [002919.CN](https://longbridge.com/en/quote/002919.CN.md)

## Related News & Research

- [CSPC’s SYS6010 Wins Third Breakthrough Therapy Tag in High-Need Cancer Indications](https://longbridge.com/en/news/297638498.md)
- [Xiaomi sets September 7 launch for 18 Fold foldable phone](https://longbridge.com/en/news/297748864.md)
- [RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology](https://longbridge.com/en/news/297642626.md)
- [XPENG Sales Up 4% in August](https://longbridge.com/en/news/297713940.md)
- [16:58 ETNanochon Performs First Case in the Chondrograft™ First in Human Clinical Study](https://longbridge.com/en/news/297830179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**